Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02414282 · ClinicalTrials.gov registry record
F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)
A clinical trial, sponsored by Tammie L. S. Benzinger, MD, PhD.
- Completed
- Registry status
- 20
- Enrollment target
NCT02414282 is a clinical trial that has completed, run by Tammie L. S. Benzinger, MD, PhD. The registered enrollment target is 20 participants.
The verdict
NCT02414282 has completed, sponsored by Tammie L. S. Benzinger, MD, PhD.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This project will collect quantitative pilot data that will allow the characterization of uptake and binding of 18F-AV-1451 (also known as F 18 T807), a novel tau imaging compound, in individuals with Progressive Posterior Cortical Dysfunction (PPCD) and logopenic variant primary progressive aphasia (lvPPA). The primary goal is to develop tau imaging technique as an antecedent biomarker of cognitive decline. The investigators propose to obtain preliminary data that will support the possibility of detecting cognitive decline in its earliest stages, before the occurrence of dementia.
Interventions
- DRUG F 18 T807
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-03 |
| Est. Completion | 2020-10-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02414282
The ClinicalTrials.gov registry entry for NCT02414282 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tammie L. S. Benzinger, MD, PhD, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which F 18 T807 is the first listed.
NCT02414282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02414282 about?
NCT02414282 is a clinical study titled "F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)". This project will collect quantitative pilot data that will allow the characterization of uptake and binding of 18F-AV-1451 (also known as F 18 T807), a novel tau imaging compound, in individuals with Progressive Posterior Cortical Dysfunction (PPCD) and logopenic variant primary progressive aphasia...
What is the current status of trial NCT02414282?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-03. Estimated completion is 2020-10-20.
What interventions are being tested in trial NCT02414282?
The interventions under investigation include: F 18 T807 (DRUG).
Who is sponsoring clinical trial NCT02414282?
This trial is sponsored by Tammie L. S. Benzinger, MD, PhD, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.